NewAmsterdam Pharma (NASDAQ:NAMS) CEO Sells $14,753,257.75 in Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CEO Michael Davidson sold 443,707 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price...